Status:
COMPLETED
Prediction of Hemodynamic Reactivity During Suspension Laryngoscopy Using Analgesia/Nociception Index (ANI)
Lead Sponsor:
Emmanuel Boselli
Conditions:
Anesthesia
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of this study is to evaluate the performance of Analgesia/Nociception Index for the prediction of hemodynamic reactivity in adult patients undergoing suspension laryngoscopy on general anesthe...
Detailed Description
Measurement of analgesia/nociception index at different time points during procedure and assessment of analgesia/nociception index to predict hemodynamic reactivity by building receiver observer's cha...
Eligibility Criteria
Inclusion
- Age 18-75 years
- Suspension laryngoscopy for diagnostic or therapeutic purposes
- Total intravenous anesthesia using propofol and remifentanil
Exclusion
- age \<18 yrs or \>75 yrs
- arrythmia
- administration of anticholinergic drugs or neuromuscular blockade reversal in the 20 previous minutes
- psychiatric diseases
- autonomic nervous system disorders (epilepsy)
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01796210
Start Date
October 1 2012
End Date
May 1 2013
Last Update
June 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Édouard Herriot, HCL
Lyon, Rhône, France, 69003